๎๊ฒ์
๎๊ฒ์
๎
Jade Biosciences Ord Shs
JBIO๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
23.355USD
-0.775-3.21%
์ข
๊ฐย 05/15, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
1.15B์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ ํ์ฌ
Jade Biosciences Ord Shs ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ - -
ํ์ฌ ์ด๋ฆ- -
์์ฅ์ผ- -
CEO- -
์ง์ ์- -
์ ํ- -
ํ๊ณ ์ฐ๋ ์ข
๋ฃ- -
์ฃผ์- -
๋์- -
์ฆ๊ถ ๊ฑฐ๋์- -
๊ตญ๊ฐ- -
์ฐํธ ๋ฒํธ- -
์ ํ- -
์น์ฌ์ดํธ- -
์ข
๋ชฉ ์ฝ๋ - -
์์ฅ์ผ- -
CEO- -
Jade Biosciences Ord Shs์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
37.81K
--
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+8.51%
Mr. Timothy P. Noyes
Mr. Timothy P. Noyes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Stephen K. Yu
Mr. Stephen K. Yu
Senior Vice President - Quality
Senior Vice President - Quality
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
37.81K
--
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+8.51%
Mr. Timothy P. Noyes
Mr. Timothy P. Noyes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
์์ต ๋ถ์
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sun, May 10
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sun, May 10
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Fidelity Management & Research Company LLC
13.72%
Fairmount Funds Management LLC
9.23%
RA Capital Management, LP
7.44%
VR Adviser, LLC
6.52%
Bellevue Asset Management AG
6.51%
๊ธฐํ
56.59%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Fidelity Management & Research Company LLC
13.72%
Fairmount Funds Management LLC
9.23%
RA Capital Management, LP
7.44%
VR Adviser, LLC
6.52%
Bellevue Asset Management AG
6.51%
๊ธฐํ
56.59%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
35.36%
Hedge Fund
24.74%
Venture Capital
20.09%
Investment Advisor/Hedge Fund
20.04%
Individual Investor
1.12%
Private Equity
1.08%
Research Firm
0.32%
Bank and Trust
0.14%
Insurance Company
0.02%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q4
161
38.26M
85.14%
--
2026Q1
243
52.32M
106.02%
+8.39M
2025Q4
225
39.61M
80.33%
+327.27K
2025Q3
219
31.65M
77.53%
-1.17M
2025Q2
222
32.33M
102.43%
+21.99M
2025Q1
207
926.72K
111.95%
-347.50K
2024Q4
207
879.69K
106.31%
-203.28K
2024Q3
202
808.07K
98.05%
-248.23K
2024Q2
199
794.81K
96.63%
-106.00K
2024Q1
171
831.84K
104.51%
-50.52K
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Fidelity Management & Research Company LLC
6.77M
13.73%
+1.98M
+41.35%
Dec 31, 2025
Fairmount Funds Management LLC
4.55M
9.23%
--
--
Dec 31, 2025
RA Capital Management, LP
3.67M
7.44%
+456.11K
+14.19%
Dec 31, 2025
VR Adviser, LLC
3.22M
6.53%
--
--
Dec 31, 2025
Bellevue Asset Management AG
3.34M
6.77%
+3.34M
--
Dec 31, 2025
Janus Henderson Investors
3.06M
6.21%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.60M
5.26%
+634.54K
+32.35%
Dec 31, 2025
Baker Bros. Advisors LP
1.64M
3.33%
+1.64M
--
Dec 31, 2025
Remedium Capital Partners, LLC
1.58M
3.2%
+1.58M
--
Dec 31, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
์ด๋ฆ
๋น์จ
iShares Micro-Cap ETF
0.08%
iShares Russell 2000 Value ETF
0.03%
Global X Russell 2000 ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 3000 ETF
0%
iShares Russell 2000 Growth ETF
0%
๋ ๋ณด๊ธฐ
iShares Micro-Cap ETF
๋น์จ0.08%
iShares Russell 2000 Value ETF
๋น์จ0.03%
Global X Russell 2000 ETF
๋น์จ0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
๋น์จ0.02%
ProShares Hedge Replication ETF
๋น์จ0.02%
ProShares UltraPro Russell2000
๋น์จ0.01%
Proshares Ultra Russell 2000
๋น์จ0.01%
iShares Russell 2000 ETF
๋น์จ0.01%
iShares Russell 3000 ETF
๋น์จ0%
iShares Russell 2000 Growth ETF
๋น์จ0%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Apr 21, 2025
Merger
35โ1
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Apr 21, 2025
Merger
35โ1
